Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA designates orphan drug for Peyronie's disease

April 19, 1996

Troglitazone NDA filing expected soon

April 19, 1996

YM-47813 revealed at 211th ACS

April 19, 1996

Taisho reports 5-HT4 agonists for GI disorders

April 19, 1996

FDA approves Prilosec + Biaxin combination for H. pylori

April 19, 1996

Byk Gulden researches anti-Helicobacter agents

April 19, 1996

FDA gives green light to Milkhaus for HP-4 clinical trial

April 19, 1996

SNAP-5399 presented at 211th ACS

April 19, 1996

XQ-870, fibrinogen antagonist presented by DuPont Merck

April 19, 1996

More antiplatelet agents from Thomae

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...